-
Something wrong with this record ?
Adaptation of an L-proline adenylation domain to use 4-propyl-L-proline in the evolution of lincosamide biosynthesis
S. Kadlčík, T. Kučera, D. Chalupská, R. Gažák, M. Koběrská, D. Ulanová, J. Kopecký, E. Kutejová, L. Najmanová, J. Janata,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
Public Library of Science (PLoS)
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2006-12-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-10-01
Medline Complete (EBSCOhost)
from 2008-01-01
Nursing & Allied Health Database (ProQuest)
from 2006-12-01
Health & Medicine (ProQuest)
from 2006-12-01
Public Health Database (ProQuest)
from 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
- MeSH
- Bacterial Proteins chemistry MeSH
- Dipeptides chemistry MeSH
- Lincomycin biosynthesis chemistry MeSH
- Lincosamides biosynthesis chemistry MeSH
- Evolution, Molecular * MeSH
- Molecular Dynamics Simulation * MeSH
- Streptomyces enzymology MeSH
- Protein Structure, Tertiary MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Clinically used lincosamide antibiotic lincomycin incorporates in its structure 4-propyl-L-proline (PPL), an unusual amino acid, while celesticetin, a less efficient related compound, makes use of proteinogenic L-proline. Biochemical characterization, as well as phylogenetic analysis and homology modelling combined with the molecular dynamics simulation were employed for complex comparative analysis of the orthologous protein pair LmbC and CcbC from the biosynthesis of lincomycin and celesticetin, respectively. The analysis proved the compared proteins to be the stand-alone adenylation domains strictly preferring their own natural substrate, PPL or L-proline. The LmbC substrate binding pocket is adapted to accommodate a rare PPL precursor. When compared with L-proline specific ones, several large amino acid residues were replaced by smaller ones opening a channel which allowed the alkyl side chain of PPL to be accommodated. One of the most important differences, that of the residue corresponding to V306 in CcbC changing to G308 in LmbC, was investigated in vitro and in silico. Moreover, the substrate binding pocket rearrangement also allowed LmbC to effectively adenylate 4-butyl-L-proline and 4-pentyl-L-proline, substrates with even longer alkyl side chains, producing more potent lincosamides. A shift of LmbC substrate specificity appears to be an integral part of biosynthetic pathway adaptation to the PPL acquisition. A set of genes presumably coding for the PPL biosynthesis is present in the lincomycin--but not in the celesticetin cluster; their homologs are found in biosynthetic clusters of some pyrrolobenzodiazepines (PBD) and hormaomycin. Whereas in the PBD and hormaomycin pathways the arising precursors are condensed to another amino acid moiety, the LmbC protein is the first functionally proved part of a unique condensation enzyme connecting PPL to the specialized amino sugar building unit.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014552
- 003
- CZ-PrNML
- 005
- 20201203122532.0
- 007
- ta
- 008
- 150420s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0084902 $2 doi
- 035 __
- $a (PubMed)24386435
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kadlčík, Stanislav $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 245 10
- $a Adaptation of an L-proline adenylation domain to use 4-propyl-L-proline in the evolution of lincosamide biosynthesis / $c S. Kadlčík, T. Kučera, D. Chalupská, R. Gažák, M. Koběrská, D. Ulanová, J. Kopecký, E. Kutejová, L. Najmanová, J. Janata,
- 520 9_
- $a Clinically used lincosamide antibiotic lincomycin incorporates in its structure 4-propyl-L-proline (PPL), an unusual amino acid, while celesticetin, a less efficient related compound, makes use of proteinogenic L-proline. Biochemical characterization, as well as phylogenetic analysis and homology modelling combined with the molecular dynamics simulation were employed for complex comparative analysis of the orthologous protein pair LmbC and CcbC from the biosynthesis of lincomycin and celesticetin, respectively. The analysis proved the compared proteins to be the stand-alone adenylation domains strictly preferring their own natural substrate, PPL or L-proline. The LmbC substrate binding pocket is adapted to accommodate a rare PPL precursor. When compared with L-proline specific ones, several large amino acid residues were replaced by smaller ones opening a channel which allowed the alkyl side chain of PPL to be accommodated. One of the most important differences, that of the residue corresponding to V306 in CcbC changing to G308 in LmbC, was investigated in vitro and in silico. Moreover, the substrate binding pocket rearrangement also allowed LmbC to effectively adenylate 4-butyl-L-proline and 4-pentyl-L-proline, substrates with even longer alkyl side chains, producing more potent lincosamides. A shift of LmbC substrate specificity appears to be an integral part of biosynthetic pathway adaptation to the PPL acquisition. A set of genes presumably coding for the PPL biosynthesis is present in the lincomycin--but not in the celesticetin cluster; their homologs are found in biosynthetic clusters of some pyrrolobenzodiazepines (PBD) and hormaomycin. Whereas in the PBD and hormaomycin pathways the arising precursors are condensed to another amino acid moiety, the LmbC protein is the first functionally proved part of a unique condensation enzyme connecting PPL to the specialized amino sugar building unit.
- 650 _2
- $a bakteriální proteiny $x chemie $7 D001426
- 650 _2
- $a dipeptidy $x chemie $7 D004151
- 650 12
- $a molekulární evoluce $7 D019143
- 650 _2
- $a linkomycin $x biosyntéza $x chemie $7 D008034
- 650 _2
- $a linkosamidy $x biosyntéza $x chemie $7 D055231
- 650 12
- $a simulace molekulární dynamiky $7 D056004
- 650 _2
- $a terciární struktura proteinů $7 D017434
- 650 _2
- $a Streptomyces $x enzymologie $7 D013302
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kučera, Tomáš, $d 1984- $7 uk2015876426 $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Chalupská, Dominika $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Gažák, Radek $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Koběrská, Markéta $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Ulanová, Dana $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Kopecký, Jan, $d 1966- $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. $7 xx0108100
- 700 1_
- $a Kutejová, Eva $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic ; Department of Biochemistry and Structural Biology, Institute of Molecular Biology, Slovac Academy of Sciences, Bratislava, Slovakia.
- 700 1_
- $a Najmanová, Lucie $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Janata, Jiří $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 8, č. 12 (2013), s. e84902
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24386435 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20201203122529 $b ABA008
- 999 __
- $a ok $b bmc $g 1072133 $s 897430
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 8 $c 12 $d e84902 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20150420